These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 16190134)

  • 21. [Neisseria meningitidis. The pathophysiological role of lipopolysaccharides in association with meningococcal disease and septic shock].
    Pedersen MØ; Pedersen DS; Pedersen M; Penkowa M
    Ugeskr Laeger; 2008 Feb; 170(6):421-6. PubMed ID: 18252172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical practice. Prevention of meningococcal disease.
    Gardner P
    N Engl J Med; 2006 Oct; 355(14):1466-73. PubMed ID: 17021322
    [No Abstract]   [Full Text] [Related]  

  • 23. Control and prevention of serogroup C meningococcal disease: evaluation and management of suspected outbreaks: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Feb; 46(RR-5):13-21. PubMed ID: 9048847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circumvention of herd immunity during an outbreak of meningococcal disease could be correlated to escape mutation in the porA gene of Neisseria meningitidis.
    Taha MK; Bichier E; Perrocheau A; Alonso JM
    Infect Immun; 2001 Mar; 69(3):1971-3. PubMed ID: 11179386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Invasive meningococcal disease in the 21st century—an update for the clinician.
    Dwilow R; Fanella S
    Curr Neurol Neurosci Rep; 2015 Mar; 15(3):2. PubMed ID: 25637287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meningococcal disease.
    Daley AJ
    Aust Fam Physician; 2003 Aug; 32(8):597-601, 603-5. PubMed ID: 12973866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of invasive meningococcal disease in the United States.
    Pelton SI
    Pediatr Infect Dis J; 2009 Apr; 28(4):329-32. PubMed ID: 19333079
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevention of bacterial meningitis: an overview of Cochrane systematic reviews.
    Prasad K; Karlupia N
    Respir Med; 2007 Oct; 101(10):2037-43. PubMed ID: 17706408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemic meningococcal disease in New Zealand: epidemiology and potential for prevention by vaccine.
    Bremner C; Lennon D; Martin D; Baker M; Rümke H
    N Z Med J; 1999 Jul; 112(1091):257-9. PubMed ID: 10448985
    [No Abstract]   [Full Text] [Related]  

  • 30. The risk of meningococcal disease in travelers and current recommendations for prevention.
    Steffen R
    J Travel Med; 2010; 17 Suppl():9-17. PubMed ID: 20849428
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of available outer membrane vesicle vaccines to control serogroup B meningococcal outbreaks.
    Taha MK; Zarantonelli ML; Alonso JM; Naess LM; Holst J; Feiring B; Rosenqvist E
    Vaccine; 2007 Mar; 25(14):2537-8. PubMed ID: 16460845
    [No Abstract]   [Full Text] [Related]  

  • 32. Meningococcal disease: risk for international travellers and vaccine strategies.
    Wilder-Smith A
    Travel Med Infect Dis; 2008 Jul; 6(4):182-6. PubMed ID: 18571105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The epidemiology of meningococcal disease in India.
    Sinclair D; Preziosi MP; Jacob John T; Greenwood B
    Trop Med Int Health; 2010 Dec; 15(12):1421-35. PubMed ID: 21054695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
    Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 2000 Jun; 49(RR-7):1-10. PubMed ID: 10902834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global epidemiology of meningococcal disease.
    Harrison LH; Trotter CL; Ramsay ME
    Vaccine; 2009 Jun; 27 Suppl 2():B51-63. PubMed ID: 19477562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2002, through 31 December, 2003.
    Can Commun Dis Rep; 2006 Apr; 32(8):97-107. PubMed ID: 16685767
    [No Abstract]   [Full Text] [Related]  

  • 38. Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy.
    Pace D
    Expert Rev Vaccines; 2009 May; 8(5):529-42. PubMed ID: 19397410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neisseria meningitidis: presentation, treatment, and prevention.
    Ferguson LE; Hormann MD; Parks DK; Yetman RJ
    J Pediatr Health Care; 2002; 16(3):119-24. PubMed ID: 12015670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neisseria meningitidis: epidemiology, treatment and prevention in adolescents.
    Brigham KS; Sandora TJ
    Curr Opin Pediatr; 2009 Aug; 21(4):437-43. PubMed ID: 19421058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.